InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by PROEHL GERALD T, PDG. Director active across 1 companies, notably Dermata Therapeutics, Inc.. In total, 4 disclosures have been recorded. Total volume traded: €170k. The latest transaction was disclosed on 23 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€42,69620,000 shares@ €2.134850.3% of flow
Common Stock
SEC:0000905718-21-001541·
Ideal exit: 20 Aug 2022 (T+270)
€42,69620,000 shares@ €2.134825.2% of flow
Common Stock
SEC:0000905718-21-001541:0·
Ideal exit: 20 Aug 2022 (T+270)
€42,13210,000 shares@ €4.213249.7% of flow
Common Stock
SEC:0000905718-21-001094·
Ideal exit: 13 May 2022 (T+270)
€42,13210,000 shares@ €4.213224.8% of flow
Common Stock
SEC:0000905718-21-001094:0·
Ideal exit: 13 May 2022 (T+270)
4 of 4 declarations
About PROEHL GERALD T
Gerald T. Proehl is the President, CEO, and Chairman at Dermata Therapeutics, Inc. He is responsible for the strategic direction of the company and the management of operations. His leadership is essential for ensuring the performance and sustainability of Dermata.
